Antifungal Activity of Selected Naphthoquinones and Their Synergistic Combination with Amphotericin B Against <i>Cryptococcus neoformans</i> H99

QR Code

Antifungal Activity of Selected Naphthoquinones and Their Synergistic Combination with Amphotericin B Against <i>Cryptococcus neoformans</i> H99

<b>Background/Objectives:</b> Cryptococcosis, caused by <i>Cryptococcus neoformans</i> and <i>Cryptococcus gattii</i> species complexes, remains a significant health concern, particularly among immunocompromised patients. The emergence of antifungal resistance and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Naira Sulany Oliveira de Sousa, Juan Diego Ribeiro de Almeida, Linnek Silva da Rocha, Izabela de Mesquita Bárcia Moreira, Flávia da Silva Fernandes, Ani Beatriz Jackisch Matsuura, Kátia Santana Cruz, Emersom Silva Lima, Érica Simplício de Souza, Hagen Frickmann, João Vicente Braga de Souza
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Antibiotics
Subjects:	<i>Cryptococcus</i> naphthoquinones amphotericin B antifungal synergy
Online Access:	https://www.mdpi.com/2079-6382/14/6/602
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Toxicity Assessment and Antifungal Potential of Copper(II) and Silver(I) Complexes with 1,10-Phenanthroline-5,6-dione Against Drug-Resistant Clinical Isolates of <i>Cryptococcus gattii</i> and <i>Cryptococcus neoformans</i>
by: Lucas Giovanini, et al.
Published: (2025-06-01)

Insights from Mass Spectrometry-Based Proteomics on <i>Cryptococcus neoformans</i>
by: Jovany Jordan Betancourt, et al.
Published: (2025-07-01)

Human Brain Organoids: A New Model to Study <i>Cryptococcus neoformans</i> Neurotropism
by: Alfred T. Harding, et al.
Published: (2025-07-01)

The Main Virulence factors of Cryptococcus neoformans
by: Sara Hayder Jabbar, et al.
Published: (2024-12-01)

An Optimized In-House Protocol for <i>Cryptococcus neoformans</i> DNA Extraction from Whole Blood: “Comparison of Lysis Buffer and Ox-Bile Methods”
by: Fredrickson B Wasswa, et al.
Published: (2025-06-01)

Determining Potential Link between Environmental and Clinical Isolates of Cryptococcus neoformans/Cryptococcus gattii Species Complexes Using Phenotypic and Genotypic Characterisation
by: Kenosi Kebabonye, et al.
Published: (2023-11-01)

The GATA-like transcription factor Gat201 determines alkaline-restricted growth in Cryptococcus neoformans
by: Elizabeth S. Hughes, et al.
Published: (2025-06-01)

Riboflavin inhibits growth and reduces virulence of Cryptococcus neoformans in vitro by membrane disruption and excessive accumulation of reactive oxygen species and exhibits efficacy against pulmonary cryptococcosis and meningitis
by: Jian Huang, et al.
Published: (2025-08-01)

Cutaneous cryptococcosis resembling keratoacanthoma
by: Alex Panizza Jalkh, et al.
Published: (2025-07-01)

EXTRACELLULAR POLYSACCHARYDES OF YEASTS’ CRYPTOCOCCUS ALBIDUS (SAITO) SKINNER
by: О. Г. Мамєєва, et al.
Published: (2008-03-01)

Antitumor activity of synthetic naphthoquinone derivatives (review)
by: E. L. Golovina, et al.
Published: (2025-03-01)

Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)

Lack of an atypical PDR transporter generates an immunogenic Cryptococcus neoformans strain that drives a dysregulated and lethal immune response in murine lungs
by: Christopher J. Winski, et al.
Published: (2025-07-01)

Clinic-morphological characteristics of Cryptococcosis in HIV-infective patients
by: I. P. Charushina, et al.
Published: (2014-09-01)

Immunization with a heat-killed prm1 deletion strain protects the host from Cryptococcus neoformans infection
by: Chao Li, et al.
Published: (2023-12-01)

CRYPTOMICSDB: Revealing the Molecular Landscape of Cryptococcosis
by: Yohana Porto Calegari-Alves, et al.
Published: (2025-05-01)

Broad Antifungal Spectrum of the Pore-Forming Peptide C14R Against <i>Cryptococcus</i> and <i>Candida</i> Species from the WHO Fungal Priority Pathogens List
by: Carolina Firacative, et al.
Published: (2025-05-01)

Design, Synthesis, and In Vitro Evaluation of 4-(Arylchalcogenyl)methyl)-1H-1,2,3-triazol-1-yl-menadione: Exploring Their Potential Against <i>Tuberculosis</i>
by: Nathália L. B. Santos, et al.
Published: (2025-05-01)

Clove Oil-Based Nanoemulsion Containing Amphotericin B as a Therapeutic Approach to Combat Fungal Infections
by: Marcel Lucas de Almeida, et al.
Published: (2025-07-01)

Cryptococcal Endocarditis in Humans—A Narrative Review
by: Petros Ioannou, et al.
Published: (2025-05-01)

Tailoring active chemical environment of naphthoquinone‐based cathodes with rapid kinetics for aqueous batteries
by: Jun Guo, et al.
Published: (2025-07-01)

Comparative efficacy of intrastromal amphotericin B versus voriconazole in treating deep-stromal refractory fungal keratitis
by: Charul Singh, et al.
Published: (2025-07-01)

Synergistic Combination of Amphotericin B and Antiseptic Miramistin May Be Effective in the Fight Against Drug-Resistant Isolates of Candida Fungi
by: M. A. Кirsanova, et al.
Published: (2022-12-01)

Resistance Candida spp. for amphotericin B in cancer patients
by: N. S. Bagirova, et al.
Published: (2016-04-01)

Last but not yeast-The many forms of Cryptococcus neoformans.
by: Piotr R Stempinski, et al.
Published: (2023-01-01)

The dynamics of Cryptococcus neoformans infection in Galleria mellonella
by: Daniel F. Q. Smith, et al.
Published: (2025-06-01)

Endovascular Infusion of Amphotericin B for the Treatment of Rhino-Orbito-Cerebral Mucormycosis: A Pilot Study Assessing Technical Feasibility and Safety
by: Subhash Kumar, et al.
Published: (2022-07-01)

Antimicrobial Peptides Act-6 and Act 8-20 Derived from Scarabaeidae Cecropins Exhibit Differential Antifungal Activity
by: Melissa Rodríguez, et al.
Published: (2025-07-01)

Cryptococcosis in Pediatric Renal Transplant Recipients: Comparative Insights from Adult Cases
by: Guido Gembillo, et al.
Published: (2025-06-01)

Comprehensive analysis of Amphotericin B: innovations and clinical applications in tropical dermatoses and beyond – A narrative review
by: Aditya K. Bubna, et al.
Published: (2025-04-01)

Synthesis of new glucosylated derivatives of 1,4-quinones
by: O. P. Bondarchuk
Published: (2014-08-01)

Comparing the results of invasive candidiasis prevention with anidulafungin vs. the lipid formulation of amphotericin B in high-risk patients in the early postoperative period after liver transplantation
by: S. V. Zhuravel, et al.
Published: (2020-06-01)

STRIPAK complex defects result in pseudosexual reproduction in Cryptococcus neoformans.
by: Patricia P Peterson, et al.
Published: (2025-06-01)

1-(Pyrrolidin-1-yl)naphtho[1,2-<i>d</i>]isoxazole
by: Ioannis E. Gerontitis, et al.
Published: (2025-04-01)

Review projecting shikonin as a therapeutic candidate in female carcinomas: a preclinical perspective
by: Pratibha Pandey, et al.
Published: (2025-07-01)

Efficacy and Safety of Amphotericin B Colloidal Dispersion via Nebulized Inhalation Combined with Intravenous Therapy for Invasive Pulmonary Fungal Disease: A Single-Center, Retrospective Cohort Study
by: Li Z, et al.
Published: (2025-07-01)

Prospects of studies on the yeast flora of sturgeons for monitoring of their state in aquaculture
by: Valeria E. Terekhova, et al.
Published: (2017-06-01)

Multivariate Analysis of UPLC-MS/MS Metabolomic Profiles in Four <i>Hiraea</i> Species (Malpighiaceae)
by: Jaqueline Munise Guimarães da Silva, et al.
Published: (2025-06-01)

Biocompatibility and Effectiveness of Amphotericin B-Loaded Metal-Organic Structures (AmB-ZIF-8) as Dermal Drug Transporters in Experimental Cutaneous Leishmaniasis
by: Carreño H, et al.
Published: (2025-05-01)

Criptococosis cutánea: manifestación inicial de una infección diseminada en un paciente con transplante renal
by: Luz Adriana Vásquez, et al.
Published: (2019-02-01)